Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | INMT | O95050 | 4/20 | 0.91 |
| ▸ | USP2 | O75604 | 2/20 | 0.91 |
| ▸ | NOS3 | P29474 | 5/20 | 0.41 |
| ▸ | NOS1 | P29475 | 5/20 | 0.41 |
| ▸ | NOS2 | P35228 | 5/20 | 0.41 |
| ▸ | ACHE | P22303 | 5/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL496207 | 1.00 | INMT (0.91) | INMTUSP2NOS3NOS1NOS2 | |
| SCHEMBL219036 | 1.00 | INMT (0.91) | INMTUSP2NOS3NOS1NOS2 | |
| SCHEMBL6859113 | 1.00 | INMT (0.91) | INMTUSP2NOS3NOS1NOS2 | |
| SCHEMBL5475300 | 1.00 | INMT (0.91) | INMTUSP2NOS3NOS1NOS2 | |
| SCHEMBL2956216 | 1.00 | INMT (0.91) | INMTUSP2NOS3NOS1NOS2 | |
| SCHEMBL3270217 | 1.00 | INMT (0.91) | INMTUSP2NOS3NOS1NOS2 | |
| SCHEMBL2956214 | 1.00 | INMT (0.91) | INMTUSP2NOS3NOS1NOS2 | |
| SCHEMBL2742282 | 1.00 | INMT (0.91) | INMTUSP2NOS3NOS1NOS2 | |
| SCHEMBL20718625 | 1.00 | INMT (0.91) | INMTUSP2NOS3NOS1NOS2 | |
| SCHEMBL2952223 | 1.00 | INMT (0.91) | INMTUSP2NOS3NOS1NOS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115397828-A | Preparation of MCL-1 inhibiting compounds by methylation in the presence of water | 美国安进公司 | 2022-11-25 | — | — | CN | disclosed |
| US-20060004019-A1 | Steroid sparing agents and methods of using same | BIOGEN IDEC INTERNATIONAL HOLDING LTD. (BM) | 2006-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060004019-A1 | Steroid sparing agents and methods of using same | IL5, FCER2, CD40 | INMT 910/4885USP2 3662/4885NOS3 2720/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.